
Aditi Dutt
Examiner (ID: 10694, Phone: (571)272-9037 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1675, 1649 |
| Total Applications | 612 |
| Issued Applications | 218 |
| Pending Applications | 78 |
| Abandoned Applications | 325 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10844273
[patent_doc_number] => 08871447
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-28
[patent_title] => 'Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence'
[patent_app_type] => utility
[patent_app_number] => 10/527678
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 16975
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10527678
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/527678 | Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence | Sep 11, 2003 | Issued |
Array
(
[id] => 5894360
[patent_doc_number] => 20060002899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Generation of dendritic cells from cd34+precursors'
[patent_app_type] => utility
[patent_app_number] => 10/525928
[patent_app_country] => US
[patent_app_date] => 2003-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6422
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20060002899.pdf
[firstpage_image] =>[orig_patent_app_number] => 10525928
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/525928 | Generation of dendritic cells from cd34+precursors | Aug 28, 2003 | Abandoned |
Array
(
[id] => 5912952
[patent_doc_number] => 20060128014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Compositions and methods for culturing stem cells'
[patent_app_type] => utility
[patent_app_number] => 10/525930
[patent_app_country] => US
[patent_app_date] => 2003-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 25646
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128014.pdf
[firstpage_image] =>[orig_patent_app_number] => 10525930
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/525930 | Compositions and methods for culturing stem cells | Aug 25, 2003 | Abandoned |
Array
(
[id] => 7795624
[patent_doc_number] => 08124330
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-28
[patent_title] => 'Screening methods for cognitive enhancers'
[patent_app_type] => utility
[patent_app_number] => 10/527950
[patent_app_country] => US
[patent_app_date] => 2003-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 14830
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/124/08124330.pdf
[firstpage_image] =>[orig_patent_app_number] => 10527950
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/527950 | Screening methods for cognitive enhancers | Aug 18, 2003 | Issued |
Array
(
[id] => 6938980
[patent_doc_number] => 20050112543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Method of screening for drugs useful in treating Alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 10/643226
[patent_app_country] => US
[patent_app_date] => 2003-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 21792
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20050112543.pdf
[firstpage_image] =>[orig_patent_app_number] => 10643226
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/643226 | Method of screening for drugs useful in treating Alzheimer's disease | Aug 18, 2003 | Abandoned |
Array
(
[id] => 5236035
[patent_doc_number] => 20070128191
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-07
[patent_title] => 'Polyclonal antibodies, preparation method thereof and use of same'
[patent_app_type] => utility
[patent_app_number] => 10/527742
[patent_app_country] => US
[patent_app_date] => 2003-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1951
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20070128191.pdf
[firstpage_image] =>[orig_patent_app_number] => 10527742
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/527742 | Polyclonal antibodies, preparation method thereof and use of same | Aug 12, 2003 | Abandoned |
Array
(
[id] => 7475112
[patent_doc_number] => 20040122216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs'
[patent_app_type] => new
[patent_app_number] => 10/612665
[patent_app_country] => US
[patent_app_date] => 2003-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 48545
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20040122216.pdf
[firstpage_image] =>[orig_patent_app_number] => 10612665
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/612665 | Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs | Jun 30, 2003 | Abandoned |
Array
(
[id] => 5661505
[patent_doc_number] => 20060252101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Modulators and modulation of the interaction between rgm and neogenin'
[patent_app_type] => utility
[patent_app_number] => 10/519132
[patent_app_country] => US
[patent_app_date] => 2003-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13323
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252101.pdf
[firstpage_image] =>[orig_patent_app_number] => 10519132
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/519132 | Modulators and modulation of the interaction between RGM and Neogenin | Jun 25, 2003 | Issued |
Array
(
[id] => 7291808
[patent_doc_number] => 20040110924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Identification and characterization of multiple splice variants of the kappa3-related opioid receptor (KOR-3) gene'
[patent_app_type] => new
[patent_app_number] => 10/606592
[patent_app_country] => US
[patent_app_date] => 2003-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11605
[patent_no_of_claims] => 80
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110924.pdf
[firstpage_image] =>[orig_patent_app_number] => 10606592
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/606592 | Identification and characterization of multiple splice variants of the kappa3-related opioid receptor (KOR-3) gene | Jun 25, 2003 | Abandoned |
Array
(
[id] => 5097304
[patent_doc_number] => 20070118913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-24
[patent_title] => 'Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases'
[patent_app_type] => utility
[patent_app_number] => 10/517439
[patent_app_country] => US
[patent_app_date] => 2003-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11590
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20070118913.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517439
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517439 | Diagnostic and therapeutic use of steroidogenic acute regulatory protein for neurodegenerative diseases | Jun 4, 2003 | Abandoned |
Array
(
[id] => 5912303
[patent_doc_number] => 20060127365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Method of cell therapy using fused cell hybrids'
[patent_app_type] => utility
[patent_app_number] => 10/515579
[patent_app_country] => US
[patent_app_date] => 2003-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 25753
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20060127365.pdf
[firstpage_image] =>[orig_patent_app_number] => 10515579
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/515579 | Method of cell therapy using fused cell hybrids | May 29, 2003 | Abandoned |
Array
(
[id] => 6634370
[patent_doc_number] => 20030211542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Assays and methods of diagnosis and treatment based on use of sodium channels as targets for amyloid beta or its aggregates'
[patent_app_type] => new
[patent_app_number] => 10/437668
[patent_app_country] => US
[patent_app_date] => 2003-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14824
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20030211542.pdf
[firstpage_image] =>[orig_patent_app_number] => 10437668
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/437668 | Assays and methods of diagnosis and treatment based on use of sodium channels as targets for amyloid beta or its aggregates | May 13, 2003 | Abandoned |
Array
(
[id] => 7393003
[patent_doc_number] => 20040038235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'A g-protein coupled receptor'
[patent_app_type] => new
[patent_app_number] => 10/311710
[patent_app_country] => US
[patent_app_date] => 2003-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10812
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038235.pdf
[firstpage_image] =>[orig_patent_app_number] => 10311710
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/311710 | A g-protein coupled receptor | May 1, 2003 | Abandoned |
Array
(
[id] => 6701546
[patent_doc_number] => 20030224426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Human G-protein chemokine receptor HSATU68'
[patent_app_type] => new
[patent_app_number] => 10/411284
[patent_app_country] => US
[patent_app_date] => 2003-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 159923
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224426.pdf
[firstpage_image] =>[orig_patent_app_number] => 10411284
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/411284 | Human G-protein chemokine receptor HSATU68 | Apr 10, 2003 | Issued |
Array
(
[id] => 895732
[patent_doc_number] => 07342103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-11
[patent_title] => 'DIRS1 antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/412749
[patent_app_country] => US
[patent_app_date] => 2003-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22468
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/342/07342103.pdf
[firstpage_image] =>[orig_patent_app_number] => 10412749
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/412749 | DIRS1 antibodies | Apr 9, 2003 | Issued |
Array
(
[id] => 6664126
[patent_doc_number] => 20030203452
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Human chemokine beta-13'
[patent_app_type] => new
[patent_app_number] => 10/406494
[patent_app_country] => US
[patent_app_date] => 2003-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21199
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203452.pdf
[firstpage_image] =>[orig_patent_app_number] => 10406494
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/406494 | Human chemokine beta-13 | Apr 3, 2003 | Abandoned |
Array
(
[id] => 5875169
[patent_doc_number] => 20060166868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Vegf peptides and their use'
[patent_app_type] => utility
[patent_app_number] => 10/507463
[patent_app_country] => US
[patent_app_date] => 2003-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3658
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166868.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507463
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507463 | Vegf peptides and their use | Mar 27, 2003 | Abandoned |
Array
(
[id] => 5625265
[patent_doc_number] => 20060263770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/508663
[patent_app_country] => US
[patent_app_date] => 2003-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 40139
[patent_no_of_claims] => 74
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263770.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508663
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508663 | Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof | Mar 20, 2003 | Abandoned |
Array
(
[id] => 6829654
[patent_doc_number] => 20030180712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'Inhibition of the beta3 subunit of L-type Ca2+ channels'
[patent_app_type] => new
[patent_app_number] => 10/392810
[patent_app_country] => US
[patent_app_date] => 2003-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12001
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180712.pdf
[firstpage_image] =>[orig_patent_app_number] => 10392810
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/392810 | Inhibition of the beta3 subunit of L-type Ca2+ channels | Mar 18, 2003 | Abandoned |
Array
(
[id] => 6796943
[patent_doc_number] => 20030175817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Method of screening for antiandrogen agent'
[patent_app_type] => new
[patent_app_number] => 10/203568
[patent_app_country] => US
[patent_app_date] => 2003-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7333
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10203568
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/203568 | Method of screening for antiandrogen agent | Mar 13, 2003 | Abandoned |